Concepedia

Craig W. Menges

CW

Statistics

Publications

23

Citations

1.7K

H-Index

20

Active since

1994

Affiliations

Fox Chase Cancer Center(Current)

University of Rochester

The Wistar Institute

Queen's University Belfast

University of Pennsylvania

Craig W. Menges is an author at Fox Chase Cancer Center specializing in oncology, malignant neoplasms, and molecular oncology.

ORCID

Publications per year

1994–2020

23

Publications

23

Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship

Irina M. Shapiro, Vihren N. Kolev, Christian M. Vidal et al. · Science Translational Medicine · 2014 · 244 citations

, , +17

Human Papillomavirus Type 16 E7 Up-regulates AKT Activity through the Retinoblastoma Protein

Craig W. Menges, Laurel A. Baglia, Randi Lapoint et al. · Cancer Research · 2006 · 170 citations · Full text

, , +17

Germline Mutation of <i>Bap1</i> Accelerates Development of Asbestos-Induced Malignant Mesothelioma

Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung et al. · Cancer Research · 2014 · 141 citations · Full text

, , +17

Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline <i>Bap1</i> Mutations

Yuwaraj Kadariya, Mitchell Cheung, Jinfei Xu et al. · Cancer Research · 2016 · 106 citations · Full text

, , +17

Constitutive activation of the Raf–MAPK pathway causes negative feedback inhibition of Ras–PI3K–AKT and cellular arrest through the EphA2 receptor

Craig W. Menges, Dennis J. McCance · Oncogene · 2007 · 104 citations

, , +15

1–5 of 23